MarketCap
Facebook
X
Telegram
Cross Country Healthcare Income Statement 2025-2008 | CCRN
Brief overview of financial results at Cross Country Healthcare
The conclusions below are based on five years of reported results. According to figures from Cross Country Healthcare, revenue changed from $836 million to $237 million over five years. Across the full period, sales moved by −71.7%; the average annual rate was −22.3%. The decline points to a contraction in the scale of the business.
The five-year change in gross profit reached −76.3%: from $203 million to $48 million. Comparing the endpoints gives gross margins of 24.2% and 20.3%. A lower margin indicates deterioration in the economics of the core business.
EBITDA changed from 3.5 million dollars to −67.6 million dollars (−2025.9%). EBITDA lagged revenue, showing weaker operating momentum. EBITDA margin moved from 0.4% to −28.6%. Cost pressure reduced operating profitability.
Net income moved from −13 million dollars at the start to −82.9 million dollars at the end. The loss widened and increased the financial risk.
The five-year change in capitalization reached +1.9%: from 320 million dollars to 326 million dollars. The market value rose well beyond the pace of financial improvement.
What the figures show
The indicators point to a weaker financial profile. The main areas of concern are declining net profitability, a low EBITDA margin and weaker operating efficiency. Investors should continue to monitor margins, costs, and earnings quality.
Annual Income Statement Cross Country Healthcare
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
326 M | 564 M | 594 M | 929 M | 1.02 B | 320 M | 366 M | 339 M | 484 M | 451 M | 454 M | 319 M | 340 M | 170 M | 190 M | 251 M | 264 M | - |
Shares |
32.4 M | 33.4 M | 35.2 M | 37 M | 36.7 M | 36.1 M | 35.8 M | 35.7 M | 35 M | 32.1 M | 31.5 M | 31.2 M | 31 M | 30.8 M | 31.1 M | 31.1 M | 30.8 M | - |
Historical Prices |
10.1 | 16.9 | 16.9 | 25.1 | 27.8 | 8.87 | 11.6 | 7.33 | 12.8 | 15.6 | 16.4 | 12.5 | 9.98 | 4.8 | 5.55 | 8.09 | 8.56 | 15.2 |
Net Income |
-82.9 M | -3.75 M | 72.6 M | 188 M | 77.6 M | -13 M | -57.7 M | -17 M | 37.5 M | 7.97 M | 4.42 M | -31.8 M | -52 M | -42.2 M | 4.1 M | -2.77 M | 6.69 M | - |
Revenue |
237 M | 310 M | 2.02 B | 2.8 B | 641 M | 836 M | 822 M | 816 M | 865 M | 834 M | 767 M | 618 M | 438 M | 443 M | 504 M | 964 K | - | - |
Gross Profit |
48 M | 62 M | 90.5 M | 139 M | 147 M | 203 M | 204 M | 210 M | 229 M | 222 M | 197 M | 158 M | 113 M | 112 M | 138 M | - | - | - |
Operating Income |
-84.4 M | -16.9 M | 113 M | 270 M | 139 M | -9.16 M | -15.7 M | -12.9 M | 11.7 M | 6.18 M | 20.6 M | -10.5 M | -8.02 M | -24.5 M | 5.91 M | -3.81 M | 17.7 M | - |
Interest Expense |
-9 K | 605 K | 8.09 M | 14.4 M | 6.87 M | 2.89 M | 5.31 M | 5.65 M | 4.21 M | 6.11 M | 6.81 M | 4.16 M | 849 K | 2.34 M | 2.86 M | 4.24 M | 6.24 M | - |
EBITDA |
-67.6 M | 1.34 M | 131 M | 282 M | 149 M | 3.51 M | 22 M | 29.3 M | 41.2 M | 41.9 M | 36.1 M | 16.8 M | 7.34 M | 2.17 M | 20.8 M | 4.23 M | 26.5 M | - |
Operating Expenses |
- | - | - | - | - | - | 196 M | 192 M | 198 M | 189 M | 169 M | 148 M | 112 M | 117 M | 127 M | - | - | - |
General and Administrative Expenses |
201 M | 233 M | 300 M | 324 M | 215 M | 174 M | 182 M | 180 M | 187 M | 180 M | 161 M | 141 M | 106 M | 109 M | 117 M | 97.4 M | 121 M | - |
All numbers in USD currency
Quarterly Income Statement Cross Country Healthcare
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
31.5 M | 32.5 M | 32.5 M | 32.3 M | 33 M | 34 M | 34.2 M | 35 M | 35.4 M | 35.9 M | - | 37.1 M | 37.5 M | 37 M | 37 M | 37 M | 36.6 M | 36.2 M | 36.2 M | 36.2 M | 36.1 M | 35.9 M | 35.9 M | 35.9 M | 35.8 M | 35.7 M | 35.6 M | 35.6 M | 35.7 M | 35.8 M | 35.8 M | 35.7 M | 35.7 M | 32.9 M | 32.3 M | 32.2 M | 32.1 M | 32 M | 32 M | 31.5 M | 31.4 M | 31.3 M | 31.3 M | 31.2 M | 31.2 M | 31.1 M | 31.1 M | 31.1 M | 31 M | 30.9 M | 30.9 M | 30.9 M | 30.8 M | 30.8 M | 30.8 M | 31.2 M | 31.1 M | 31.1 M |
Net Income |
-4.27 M | -4.77 M | -6.66 M | -490 K | 2.56 M | -16 M | 2.69 M | 12.8 M | 21.3 M | 29.4 M | - | 34.8 M | 52.9 M | 62 M | 77.6 M | 23.4 M | 11.5 M | 19.4 M | 4.61 M | -1.33 M | -14.2 M | -2.09 M | -1.14 M | -3.13 M | -51.7 M | -1.77 M | -19.7 M | -441 K | 1.54 M | 1.64 M | 28 M | 6.72 M | 4.85 M | -2.01 M | -7.88 M | 14.1 M | -17.2 M | 19 M | -6.1 M | 5.01 M | 2.57 M | 2.93 M | -20.2 M | -7.6 M | -3.18 M | -782 K | -52.6 M | 914 K | -1.46 M | 1.16 M | -9.53 M | -17.6 M | -14.5 M | -584 K | 532 K | 1.79 M | 1.57 M | 207 K |
Revenue |
241 M | 250 M | 274 M | 293 M | 315 M | 340 M | 379 M | 442 M | 541 M | 623 M | - | 636 M | 754 M | 789 M | 641 M | 375 M | 332 M | 329 M | 216 M | 194 M | 217 M | 210 M | 215 M | 209 M | 203 M | 195 M | 201 M | 201 M | 205 M | 210 M | 220 M | 228 M | 209 M | 208 M | - | 1.3 M | 1.3 M | 1.3 M | - | 3 M | 4 M | 3 M | - | 6 M | 3.2 M | 2.3 M | - | 1.2 M | 1.16 M | 1.16 M | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 147 M | 83.8 M | 72.6 M | 71.5 M | 54.4 M | 48 M | 50.7 M | 49.6 M | 53.2 M | 51 M | 51.6 M | 48.3 M | 50.6 M | 51.6 M | 53.7 M | 53.8 M | 58.3 M | 60.5 M | 56.5 M | 53.3 M | 57.6 M | 58.2 M | 54.8 M | 51 M | 50.5 M | 51.5 M | 48.4 M | 47 M | 47.6 M | 47.3 M | 32.4 M | 30.4 M | 28.6 M | 28.2 M | 27.8 M | 28.9 M | 27.9 M | 27.5 M | 27.1 M | 29 M | 30.2 M | 30.7 M | 30 M | 28.5 M |
Operating Income |
-4.16 M | -5.97 M | -5.86 M | -977 K | 2.85 M | -19.2 M | 2.92 M | 20.3 M | 35.2 M | 43.8 M | - | 52.2 M | 78.8 M | 90.6 M | - | 26.4 M | 15.9 M | 21 M | - | -381 K | -13.7 M | -754 K | - | 119 K | -15.1 M | -2.69 M | - | 2.64 M | 4.34 M | 4.25 M | - | 8.37 M | 6.45 M | 3.26 M | - | 9.33 M | -17 M | 5.16 M | - | 6.87 M | 4.32 M | 3.72 M | - | 1.76 M | -1.87 M | -1.49 M | - | 914 K | -1.63 M | -199 K | - | -1.24 M | -21.4 M | -914 K | - | 4.16 M | 2.6 M | 1.06 M |
Interest Expense |
14 K | 28 K | -23 K | -60 K | -21 K | -23 K | 1.06 M | -139 K | -11 K | 3.69 M | - | 3.5 M | 3.86 M | 3.52 M | - | 2.18 M | 1.2 M | 671 K | - | 608 K | 744 K | 867 K | - | 1.4 M | 1.44 M | 1.42 M | - | 1.51 M | 1.45 M | 1.27 M | - | 1.22 M | 535 K | 1.22 M | - | 1.44 M | 1.61 M | 1.64 M | - | 1.65 M | 1.77 M | 1.74 M | - | 1.83 M | 289 K | 255 K | - | 190 K | 164 K | 280 K | - | 698 K | 581 K | 629 K | - | 730 K | 722 K | 728 K |
EBITDA |
-486 K | -1.88 M | -1.76 M | 3.8 M | 7.35 M | -14.5 M | 7.56 M | 24.8 M | 39.6 M | 48.7 M | - | 55.4 M | 82.3 M | 93.4 M | - | 29.1 M | 18.1 M | 23.2 M | - | 2.87 M | -9.76 M | 2.54 M | - | 3.03 M | -11.5 M | 296 K | - | 5.54 M | 7.3 M | 7.16 M | - | 11.2 M | 8.73 M | 5.45 M | - | 11.4 M | -14.6 M | 7.58 M | - | 12.7 M | 8.24 M | 5.66 M | - | 7.14 M | 1.49 M | 268 K | - | 1.8 M | -588 K | 823 K | - | -210 K | -20 M | 484 K | - | 5.7 M | 4.41 M | 2.9 M |
General and Administrative Expenses |
45.8 M | 46.9 M | 50 M | 52.5 M | 54.3 M | 60.3 M | 63.3 M | 69.6 M | 78.9 M | 84.3 M | - | 80.7 M | 86 M | 76.9 M | - | 52.8 M | 50.3 M | 46.3 M | - | 40.8 M | 42.3 M | 45.9 M | - | 44.4 M | 45.9 M | 46 M | - | 44.1 M | 45.3 M | 45.6 M | - | 47.3 M | 46.6 M | 47.2 M | - | 45.9 M | 44.7 M | 42.9 M | - | 39.2 M | 40.9 M | 41.2 M | - | 40.9 M | 29.2 M | 29.5 M | - | 25.5 M | 26.6 M | 27.1 M | - | 26.8 M | 27.6 M | 27.9 M | - | 29.1 M | 29.5 M | 28.9 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Cross Country Healthcare (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Consulting industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Hudson Global
HSON
|
- | 0.05 % | $ 30.3 M |  USA |
 |
Global Internet of People
SDH
|
- | 1.0 % | $ 49.8 M |  China |
 |
BGSF
BGSF
|
$ 5.37 | 0.19 % | $ 59.5 M | USA |
 |
ASGN Incorporated
ASGN
|
- | - | $ 1.03 B | USA |
 |
HeadHunter Group PLC
HHR
|
- | - | - |  Cyprus |
 |
Forrester Research
FORR
|
$ 12.38 | 1.39 % | $ 235 M | USA |
 |
IHS Markit Ltd.
INFO
|
- | -1.21 % | $ 50.9 B |  Bermuda |
 |
51job, Inc.
JOBS
|
- | -0.05 % | $ 4.11 B | China |
 |
Magal Security Systems Ltd.
MAGS
|
- | -3.95 % | $ 90.2 M |  Israel |
 |
DHI Group
DHX
|
$ 4.05 | 1.22 % | $ 181 M | USA |
 |
Equifax
EFX
|
$ 194.35 | 2.17 % | $ 23.9 B | USA |
 |
Heidrick & Struggles International
HSII
|
- | - | $ 1.2 B | USA |
 |
Franklin Covey Co.
FC
|
$ 20.37 | 0.1 % | $ 263 M | USA |
 |
Exponent
EXPO
|
$ 71.53 | 0.53 % | $ 3.64 B | USA |
 |
FTI Consulting
FCN
|
$ 153.74 | 1.15 % | $ 5 B | USA |
 |
Staffing 360 Solutions
STAF
|
- | -23.82 % | $ 7.81 M | USA |
 |
Nielsen Holdings plc
NLSN
|
- | 0.02 % | $ 10.1 B |  Niderland |
 |
Paychex
PAYX
|
$ 127.04 | 0.44 % | $ 45.6 B | USA |
 |
ShiftPixy
PIXY
|
- | -14.3 % | $ 3.31 M | USA |
 |
GEE Group
JOB
|
$ 0.25 | 0.43 % | $ 27.4 M | USA |
 |
Professional Diversity Network
IPDN
|
$ 0.12 | 11.12 % | $ 370 K | USA |
 |
Kforce
KFRC
|
$ 58.1 | 0.31 % | $ 1.03 B | USA |
 |
Korn Ferry
KFY
|
$ 86.28 | 1.77 % | $ 4.44 B | USA |
|
7GC & Co. Holdings
VII
|
- | - | $ 124 M | USA |
 |
ManpowerGroup
MAN
|
$ 62.39 | 0.29 % | $ 2.91 B | USA |
 |
TrueBlue
TBI
|
$ 10.7 | 0.38 % | $ 319 M | USA |
 |
Booz Allen Hamilton Holding Corporation
BAH
|
$ 75.24 | 0.53 % | $ 9.18 B | USA |
 |
Resources Connection
RGP
|
$ 4.25 | 0.59 % | $ 143 M | USA |
 |
Barrett Business Services
BBSI
|
$ 34.37 | 0.64 % | $ 880 M | USA |
 |
Insperity
NSP
|
$ 53.54 | 3.28 % | $ 2.03 B | USA |
 |
HireQuest
HQI
|
$ 16.38 | 2.18 % | $ 229 M | USA |
 |
Robert Half International
RHI
|
$ 45.31 | 0.8 % | $ 4.54 B | USA |
 |
TriNet Group
TNET
|
$ 70.27 | 1.06 % | $ 3.37 B | USA |
 |
TransUnion
TRU
|
$ 85.67 | 1.18 % | $ 16.7 B | USA |
 |
Huron Consulting Group
HURN
|
$ 159.84 | 0.01 % | $ 2.79 B | USA |
 |
Upwork
UPWK
|
$ 9.02 | 1.12 % | $ 1.2 B | USA |
 |
Verisk Analytics
VRSK
|
$ 191.77 | 0.39 % | $ 26.8 B | USA |
 |
Volt Information Sciences, Inc.
VOLT
|
$ 35.59 | 0.12 % | $ 765 M | USA |
 |
Kelly Services Class B
KELYB
|
$ 23.27 | 1.22 % | $ 817 M | USA |
 |
Mastech Digital
MHH
|
$ 7.47 | 1.36 % | $ 87.8 M | USA |
 |
Greenpro Capital Corp.
GRNQ
|
$ 13.5 | 3.45 % | $ 108 M | China |
 |
ICF International
ICFI
|
$ 90.22 | 0.47 % | $ 1.66 B | USA |
 |
Kelly Services Class A
KELYA
|
$ 17.28 | 1.11 % | $ 607 M | USA |
 |
CRA International
CRAI
|
$ 174.99 | 1.44 % | $ 1.16 B | USA |
 |
Automatic Data Processing
ADP
|
$ 287.48 | 0.98 % | $ 116 B | USA |
 |
Thomson Reuters Corporation
TRI
|
$ 106.23 | 1.38 % | $ 47.7 B | USA |